Embodiments of the invention provide devices, systems, and methods that precisely identify a minimum of one predetermined spot which is hidden under a skin. The system comprises a locator device and corresponding implanted target device. The port locator device preferably comprises one magnet with north and south magnetic pole, a body and a suspending component. The body may utilize specific geometry which improves accuracy. The implanted target device may include at least one magnet and at least one target or a plurality of targets and at least one magnet. Various configurations can be provided that precisely identify a single spot or a plurality of spots which are hidden under a skin.

[Problem] To accurately check a usage status of a medical product such as a damage status of the medical product or existence or nonexistence of the medical product.

[Solution] A medical product (80) is configured to include a light-emissive septum (83) (constituent member) which includes a luminescent agent emitting near-infrared fluorescence according to irradiation of excitation light on a surface thereof. Even in a case where a portion of the septum is separated as a core (83a) (separate piece) due to damage, the luminescent agent is also included on a surface of the core. A medical product usage status checking apparatus (10) is configured to include a medical product which emits the near-infrared fluorescence, an irradiation unit (130) which irradiates the medical product with excitation light which excites the luminescent agent, an optical filter (140) which blocks the excitation light and transmits the near-infrared fluorescence emitted by the luminescent agent, a camera (15) (imaging unit) which receives the near-infrared fluorescence passing through the optical filter, and a monitor (160) (display unit) which displays an image captured by the camera. An image based on the near-infrared fluorescence of the septum is displayed on the monitor and in a case where damage occurs in the septum, an image based on the near-infrared fluorescence of the core is displayed on the monitor.

A power transmission unit includes a second coil which contactlessly transmits power, a power reception unit includes a first coil that receives the power transmitted from the power transmission unit, and a medical instrument includes the power reception unit and is embedded in a body. The medical instrument includes a notification unit that is composed of a plurality of light emitting units that provides notification that a relative positional relationship between the power transmission unit and the power reception unit has reached a predetermined state by emitting light using the power received at the power reception unit when the predetermined state is reached by the movement of the power transmission unit. A soft unit into which an injection needle is inserted, the plurality of light emitting units being arranged so as to extend along an outer edge of the soft unit.

A cannulation chamber is provided for use with an arteriovenous graft including a flexible conduit. The cannulation chamber comprises an elongated body defining an annular passageway having a longitudinal axis extending between a first end and a second end. The body receives and surrounds the conduit in the passageway. The body comprises a self-sealing material and a cannulation port that exposes the self-sealing material. A flexible resilient elongated back plate is embedded in the body of the cannulation chamber such that the back plate extends generally parallel with and may partially surround the passageway. The back plate is formed of a substantially rigid material such that when a needle is inserted through the cannulation port and the self-sealing material, the needle is inhibited or prevented from extending through the back plate.

A medical device comprising an access port locator configured to locate a subcutaneous access port located beneath a skin surface of a host, the access port locator including at least one annular ring having first and second opposing ends and a longitudinal access, the annular ring positionable on the skin surface of the host with the first end of the annular ring in contact with the skin surface and the longitudinal axis of the annular ring substantially perpendicular to the skin surface; at least one stabilizing flange configured to stabilize the access port locator on the skin surface, the stabilizing flange extending outward from the annular ring substantially perpendicular to the longitudinal access of the annular ring; and at least one need needle guard configured to shield a hand of a user of the access port locator when the hand is positioned on the stabilizing flange.

An access port for providing subcutaneous access to a patient is disclosed. In one embodiment, the port includes an internal body defining a fluid cavity that is accessible via a septum. A compliant outer cover including silicone is disposed about at least a portion of the body. A flange is included with the port body and is covered by the outer cover. The flange radially extends about a perimeter of the port body proximate the septum so as to impede penetration of a needle substantially into the outer cover in instances where the needle misses the septum. The flange can further include both an anchoring feature for securing the outer cover to the port body and an identification feature observable via x-ray imaging technology for conveying information indicative of at least one attribute of the access port. The outer cover provides a suitable surface for application of an antimicrobial/antithrombotic coating.

A venous access port assembly having a base, a peripheral surface, and a septum. The base defines an interior reservoir. The peripheral surface includes integrally molded X-ray discernable indicia identifying that the assembly is rated for power injection. The X-ray discernable indicia may extend through a height of the peripheral surface from a top surface to a bottom surface thereof. According to one aspect, the peripheral surface may be formed from X-ray discernable material, and the X-ray discernable indicia may be formed from the X-ray discernable material, or they may be formed by voids in the X-ray discernable material. According to another aspect, the peripheral surface may be formed from a radiotransparent or radiolucent material and applied with a radiopaque agent, and the X-ray discernable indicia may be one or more voids in the radiopaque agent or may be portions of the peripheral surface applied with the radiopaque agent.

An insertion device to assist in accessing an access port that has been subcutaneously implanted in the body of a patient is disclosed. The implanted access port is accessed by a needle of a needle assembly, such as a needle-based infusion set. The insertion device may include a body having a stabilizing portion and a guide portion. The stabilizing portion stabilizes a position of the implanted access port when the body is placed on the skin of the patient atop the implanted access port. The guide portion is designed to guide a needle of the needle assembly along a predetermined path such that the needle transcutaneously pierces a septum of the implanted access port.

An implantable vascular access device includes a fluid, a self-sealing cover disposed over the reservoir, and an outlet port configured to mate with a catheter, the outlet port fluidically coupled to the fluid reservoir. One or more sensors coupled to the device are configured to capture physiological data while the device is implanted within a patient. The device also includes a data communications unit configured to receive physiological data from the one or more sensors, obfuscate the physiological data, and transmit the obfuscated physiological data to one or more remote computing devices. The device may also be inductively powered and/or can emit a localization signal in response to wireless interrogation.

A drug delivery device includes a housing, a cartridge received within the housing, with the cartridge configured to receive a medicament, a drive assembly received within the housing and configured to engage the cartridge and dispense medicament from the cartridge, and a needle actuator assembly received within the housing, with the needle actuator assembly including a patient needle configured to pierce a patient's skin. A bottom surface of the housing defines a port interface configured to receive an implanted injection port.